Undisclosed Antiretroviral Drug Use in a Multinational Clinical Trial (HIV Prevention Trials Network 052)
Jessica M. Fogel(Johns Hopkins University), Susan H. Eshleman(Johns Hopkins University), Myron S. Cohen(University of North Carolina at Chapel Hill), Beatriz Grinsztejn(Fundação Oswaldo Cruz), Kenneth H. Mayer(Miriam Hospital), Suwat Chariyalertsak(Chiang Mai University), Estelle Piwowar‐Manning(Johns Hopkins University), Johnstone Kumwenda(Blantyre Institute for Community Ophthalmology), Victor Mudhune(Kenya Medical Research Institute), James Hakim(University of Zimbabwe), Marybeth McCauley(Family Health International 360), Ravindre Panchia(Chris Hani Baragwanath Hospital), Ian Sanne(University of the Witwatersrand), Craig W. Hendrix(Unknown), Namandjé N. Bumpus(Johns Hopkins University), Theresa Gamble(University of Utah), José Henrique Pilotto(Universidade Iguaçu), Ying Chen(Chinese Academy of Sciences), Nagalingeswaran Kumarasamy(YR Gaitonde Centre for AIDS Research and Education), Joseph Makhema(University of Namur), San-San Ou(Fred Hutch Cancer Center), Teresa L. Parsons(Johns Hopkins University), Mina C. Hosseinipour, Lei Wang(Shanghai Jiao Tong University), Breno Santos(Hospital Nossa Senhora da Conceição)
Cited by 80
Related Papers
Prevention of HIV-1 Infection with Early Antiretroviral Therapy
|New England Journal of Medicine|2011|7k
Antiretroviral Prophylaxis for HIV Prevention in Heterosexual Men and Women
|New England Journal of Medicine|2012|3.3k
Safety and Efficacy of Single-Dose Ad26.COV2.S Vaccine against Covid-19
|New England Journal of Medicine|2021|2.6k
Antiretroviral Therapy for the Prevention of HIV-1 Transmission
|New England Journal of Medicine|2016|1.7k
Cabotegravir for HIV Prevention in Cisgender Men and Transgender Women
|New England Journal of Medicine|2021|891